(Q38122519)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Paolo Calabresi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Anna Castrioto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Massimiliano Di Filippo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

811-821

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Non-motor symptoms of Parkinson's disease: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Non-dopaminergic treatments in development for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Milestones in Parkinson's disease--clinical and pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Personality, addiction, dopamine: insights from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The hippocampal-VTA loop: controlling the entry of information into long-term memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Reward-motivated learning: mesolimbic activation precedes memory formation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Integrating hippocampus and striatum in decision-making.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine and adaptive memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Striatum-hippocampus balance: from physiological behavior to interneuronal pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The hippocampal-striatal axis in learning, prediction and goal-directed behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine action on hippocampal pyramidal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: an in vitro study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Effects of dopamine, D-1 and D-2 dopaminergic agonists on the excitability of hippocampal CA1 pyramidal cells in guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine-mediated disinhibition in the CA1 region of rat hippocampus via D3 receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine profoundly suppresses excitatory transmission in neonatal rat hippocampus via phosphatidylinositol-linked D1-like receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine selectively potentiates hippocampal mossy fiber to CA3 synaptic transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Levodopa: faster and better word learning in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

By carrot or by stick: cognitive reinforcement learning in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Getting formal with dopamine and reward

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Regulation of firing of dopaminergic neurons and control of goal-directed behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Feedback timing modulates brain systems for learning in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Limbic and cortical information processing in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Impulse control disorders in Parkinson's disease: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Impulse control disorders in Parkinson disease: a multicenter case--control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Functional abnormalities underlying pathological gambling in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Reversal learning in Parkinson's disease depends on medication status and outcome valence.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Parkinson's disease is associated with hippocampal atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Treatment of dementia with Lewy bodies and Parkinson's disease dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Cholinergic modulation on spike timing-dependent plasticity in hippocampal CA1 network.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopaminergic modulation of LTP induction in the dentate gyrus of intact brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Studies on long-term potentiation of the population spike component of hippocampal field potential by the tetanic stimulation of the perforant path rats: effects of a dopamine agonist, SKF-38393.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

CNS dopamine transmission mediated by noradrenergic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine induces LTP differentially in apical and basal dendrites through BDNF and voltage-dependent calcium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

100 years of Lewy pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Pathological roles of α-synuclein in neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The link between the GBA gene and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The substantia nigra pars compacta of the Göttingen minipig: an anatomical and stereological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Depression and hippocampal neurogenesis: a road to remission?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Regulation of adult neurogenesis in the hippocampus by stress, acetylcholine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Repairing the parkinsonian brain with neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

A reassessment of risks and benefits of dopamine agonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine and memory: modulation of the persistence of memory for novel hippocampal NMDA receptor-dependent paired associates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Dopamine-mediated regulation of corticostriatal synaptic plasticity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

Distinct hippocampal and basal ganglia contributions to probabilistic learning and reversal.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970118-2

7 January 2021

10.1016/S1474-4422(13)70118-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867199%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference